| 0 |
CARCINOID TUMOUR IN THE LARGE INTESTINE |
1 |
0.0526 |
| 1 |
UROBILINOGEN URINE |
1 |
0.0370 |
| 2 |
CORTISOL DEFICIENCY |
1 |
0.0345 |
| 3 |
MYCOSIS FUNGOIDES STAGE IV |
1 |
0.0345 |
| 4 |
POST-TRAUMATIC AMNESTIC DISORDER |
1 |
0.0154 |
| 5 |
CORYNEBACTERIUM TEST POSITIVE |
1 |
0.0141 |
| 6 |
COMPLEMENT FACTOR INCREASED |
1 |
0.0119 |
| 7 |
PERICORONITIS |
1 |
0.0110 |
| 8 |
CREATINE PHOSPHOKINASE DECREASED |
1 |
0.0105 |
| 9 |
ABSCESS STERILE |
1 |
0.0068 |
| 10 |
RADIATION PROCTITIS |
1 |
0.0054 |
| 11 |
COMPLEMENT FACTOR C4 DECREASED |
1 |
0.0052 |
| 12 |
METASTASES TO EYE |
1 |
0.0046 |
| 13 |
METATARSALGIA |
1 |
0.0042 |
| 14 |
COMPLEMENT FACTOR C3 DECREASED |
1 |
0.0041 |
| 15 |
SKULL FRACTURED BASE |
1 |
0.0040 |
| 16 |
CATHETER SITE CELLULITIS |
1 |
0.0034 |
| 17 |
DOUBLE STRANDED DNA ANTIBODY POSITIVE |
1 |
0.0031 |
| 18 |
PNEUMOCEPHALUS |
1 |
0.0030 |
| 19 |
PRODUCT QUALITY ISSUE |
379 |
0.0028 |
| 20 |
INCORRECT PRODUCT DOSAGE FORM ADMINISTERED |
1 |
0.0024 |
| 21 |
LENTICULAR OPACITIES |
1 |
0.0023 |
| 22 |
VULVOVAGINAL INFLAMMATION |
1 |
0.0022 |
| 23 |
T-LYMPHOCYTE COUNT DECREASED |
1 |
0.0015 |
| 24 |
BRAIN CONTUSION |
1 |
0.0014 |
| 25 |
AMINO ACID LEVEL INCREASED |
1 |
0.0013 |
| 26 |
KETONURIA |
1 |
0.0012 |
| 27 |
PENILE HAEMORRHAGE |
1 |
0.0012 |
| 28 |
HYPOPITUITARISM |
2 |
0.0011 |
| 29 |
PRODUCT SHAPE ISSUE |
1 |
0.0011 |
| 30 |
ANTINUCLEAR ANTIBODY INCREASED |
1 |
0.0010 |
| 31 |
BLADDER DYSFUNCTION |
1 |
0.0010 |
| 32 |
GASTROINTESTINAL VIRAL INFECTION |
1 |
0.0010 |
| 33 |
EXOPHTHALMOS |
2 |
0.0009 |
| 34 |
JC POLYOMAVIRUS TEST POSITIVE |
1 |
0.0009 |
| 35 |
BLADDER DISCOMFORT |
1 |
0.0008 |
| 36 |
SLOW RESPONSE TO STIMULI |
1 |
0.0008 |
| 37 |
ANION GAP INCREASED |
1 |
0.0007 |
| 38 |
IMMUNOGLOBULINS DECREASED |
1 |
0.0007 |
| 39 |
MENINGITIS BACTERIAL |
1 |
0.0007 |
| 40 |
SKIN STRIAE |
1 |
0.0007 |
| 41 |
URINE KETONE BODY PRESENT |
1 |
0.0006 |
| 42 |
STUPOR |
2 |
0.0006 |
| 43 |
COSTOCHONDRITIS |
1 |
0.0006 |
| 44 |
THYROIDECTOMY |
1 |
0.0006 |
| 45 |
CONJUNCTIVAL HYPERAEMIA |
2 |
0.0006 |
| 46 |
WHITE BLOOD CELLS URINE POSITIVE |
1 |
0.0005 |
| 47 |
INTENTIONAL MISUSE |
1 |
0.0005 |
| 48 |
PATIENT DISSATISFACTION WITH TREATMENT |
1 |
0.0005 |
| 49 |
BREAST DISORDER |
1 |
0.0005 |
| 50 |
SELF-MEDICATION |
2 |
0.0005 |
| 51 |
HALLUCINATIONS, MIXED |
2 |
0.0005 |
| 52 |
JAW FRACTURE |
1 |
0.0005 |
| 53 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
1 |
0.0005 |
| 54 |
METASTASES TO BONE |
7 |
0.0004 |
| 55 |
VITILIGO |
1 |
0.0004 |
| 56 |
URINARY HESITATION |
1 |
0.0004 |
| 57 |
PRODUCT CONTAMINATION PHYSICAL |
1 |
0.0004 |
| 58 |
PROTEIN TOTAL INCREASED |
1 |
0.0004 |
| 59 |
ALCOHOL POISONING |
1 |
0.0004 |
| 60 |
ABDOMINAL RIGIDITY |
1 |
0.0004 |
| 61 |
FAECALOMA |
2 |
0.0004 |
| 62 |
PANCREATIC CARCINOMA METASTATIC |
1 |
0.0004 |
| 63 |
ESCHERICHIA SEPSIS |
1 |
0.0003 |
| 64 |
CREPITATIONS |
1 |
0.0003 |
| 65 |
RESPIRATORY RATE DECREASED |
1 |
0.0003 |
| 66 |
PRODUCT USE COMPLAINT |
5 |
0.0003 |
| 67 |
DRUG INEFFECTIVE |
416 |
0.0003 |
| 68 |
LYME DISEASE |
1 |
0.0003 |
| 69 |
SUPRAVENTRICULAR EXTRASYSTOLES |
1 |
0.0003 |
| 70 |
CARBOHYDRATE ANTIGEN 125 INCREASED |
1 |
0.0003 |
| 71 |
TYPE I HYPERSENSITIVITY |
1 |
0.0003 |
| 72 |
FRUSTRATION |
1 |
0.0003 |
| 73 |
AMYLASE INCREASED |
1 |
0.0003 |
| 74 |
THROAT CLEARING |
1 |
0.0003 |
| 75 |
PROTEIN TOTAL DECREASED |
1 |
0.0003 |
| 76 |
SENSATION OF HEAVINESS |
1 |
0.0003 |
| 77 |
VULVOVAGINAL MYCOTIC INFECTION |
1 |
0.0003 |
| 78 |
FOREIGN BODY |
1 |
0.0002 |
| 79 |
ENURESIS |
1 |
0.0002 |
| 80 |
PERIPHERAL ISCHAEMIA |
1 |
0.0002 |
| 81 |
INCREASED TENDENCY TO BRUISE |
2 |
0.0002 |
| 82 |
SINUS TACHYCARDIA |
3 |
0.0002 |
| 83 |
EXPIRED DRUG ADMINISTERED |
1 |
0.0002 |
| 84 |
PROTEIN URINE PRESENT |
1 |
0.0002 |
| 85 |
PRODUCT PHYSICAL ISSUE |
4 |
0.0002 |
| 86 |
PARTIAL SEIZURES |
1 |
0.0002 |
| 87 |
PRODUCT SIZE ISSUE |
1 |
0.0002 |
| 88 |
GINGIVITIS |
1 |
0.0002 |
| 89 |
JAW DISORDER |
1 |
0.0002 |
| 90 |
CHOKING SENSATION |
1 |
0.0002 |
| 91 |
MACULAR OEDEMA |
1 |
0.0002 |
| 92 |
GLUCOSE TOLERANCE IMPAIRED |
1 |
0.0002 |
| 93 |
VULVOVAGINAL BURNING SENSATION |
1 |
0.0002 |
| 94 |
CONCOMITANT DISEASE AGGRAVATED |
1 |
0.0002 |
| 95 |
EXPIRED PRODUCT ADMINISTERED |
5 |
0.0002 |
| 96 |
PRODUCT ADMINISTRATION ERROR |
3 |
0.0001 |
| 97 |
METASTASES TO LYMPH NODES |
1 |
0.0001 |
| 98 |
DISEASE RECURRENCE |
7 |
0.0001 |
| 99 |
LYMPHOEDEMA |
1 |
0.0001 |
| 100 |
LARGE INTESTINE POLYP |
1 |
0.0001 |
| 101 |
DEFAECATION URGENCY |
1 |
0.0001 |
| 102 |
RETINAL HAEMORRHAGE |
1 |
0.0001 |
| 103 |
BRONCHOSPASM |
2 |
0.0001 |
| 104 |
LIQUID PRODUCT PHYSICAL ISSUE |
1 |
0.0001 |
| 105 |
GASTROENTERITIS |
2 |
0.0001 |
| 106 |
ORAL DISORDER |
1 |
0.0001 |
| 107 |
KETOACIDOSIS |
1 |
0.0001 |
| 108 |
CHROMATURIA |
3 |
0.0001 |
| 109 |
TENDON PAIN |
1 |
0.0001 |
| 110 |
BLOOD COUNT ABNORMAL |
2 |
0.0001 |
| 111 |
BOWEL MOVEMENT IRREGULARITY |
1 |
0.0001 |
| 112 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
0.0001 |
| 113 |
CYANOSIS |
2 |
0.0001 |
| 114 |
DRUG SCREEN POSITIVE |
1 |
0.0001 |
| 115 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 116 |
MIOSIS |
1 |
0.0001 |
| 117 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 118 |
ORTHOSTATIC HYPOTENSION |
2 |
0.0001 |
| 119 |
PALLOR |
3 |
0.0001 |
| 120 |
TINNITUS |
5 |
0.0001 |
| 121 |
HEPATIC ENCEPHALOPATHY |
1 |
0.0001 |
| 122 |
BLOOD URINE PRESENT |
2 |
0.0001 |
| 123 |
PRODUCT PACKAGING ISSUE |
1 |
0.0001 |
| 124 |
RED BLOOD CELL COUNT DECREASED |
3 |
0.0001 |
| 125 |
MOTOR DYSFUNCTION |
1 |
0.0001 |
| 126 |
INCONTINENCE |
1 |
0.0001 |
| 127 |
BREAST CANCER METASTATIC |
1 |
0.0001 |
| 128 |
RECTAL HAEMORRHAGE |
4 |
0.0001 |
| 129 |
SKIN LACERATION |
1 |
0.0001 |
| 130 |
ASPIRATION |
1 |
0.0001 |
| 131 |
SKIN INFECTION |
1 |
0.0001 |
| 132 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 133 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
| 134 |
MICTURITION URGENCY |
1 |
0.0001 |
| 135 |
INTERNAL HAEMORRHAGE |
1 |
0.0001 |
| 136 |
BLOOD IRON DECREASED |
1 |
0.0001 |
| 137 |
NOCTURIA |
1 |
0.0001 |
| 138 |
MUSCLE SPASTICITY |
1 |
0.0001 |
| 139 |
HYPERCALCAEMIA |
1 |
0.0001 |
| 140 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 141 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
2 |
0.0001 |
| 142 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 143 |
TOOTH INFECTION |
1 |
0.0001 |
| 144 |
DISORIENTATION |
3 |
0.0001 |
| 145 |
PRODUCT TASTE ABNORMAL |
1 |
0.0001 |
| 146 |
HUNGER |
1 |
0.0001 |
| 147 |
DIALYSIS |
1 |
0.0001 |
| 148 |
SUBDURAL HAEMATOMA |
1 |
0.0001 |
| 149 |
UNDERDOSE |
5 |
0.0001 |
| 150 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 151 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 152 |
APHASIA |
2 |
0.0001 |
| 153 |
CONTRAINDICATED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 154 |
OSTEOPENIA |
1 |
0.0001 |
| 155 |
COGNITIVE DISORDER |
3 |
0.0001 |
| 156 |
PSYCHOMOTOR HYPERACTIVITY |
1 |
0.0001 |
| 157 |
FACE OEDEMA |
1 |
0.0001 |
| 158 |
DELIRIUM |
2 |
0.0001 |
| 159 |
METASTASES TO LIVER |
1 |
0.0001 |
| 160 |
COLD SWEAT |
1 |
0.0001 |
| 161 |
ADVERSE DRUG REACTION |
5 |
0.0001 |
| 162 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 163 |
HAEMATOCHEZIA |
3 |
0.0001 |
| 164 |
ABDOMINAL DISCOMFORT |
9 |
0.0001 |
| 165 |
HEPATIC CIRRHOSIS |
1 |
0.0001 |
| 166 |
PROTEINURIA |
1 |
0.0001 |
| 167 |
PRODUCT USE IN UNAPPROVED INDICATION |
13 |
0.0001 |
| 168 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 169 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 170 |
ERUCTATION |
1 |
0.0001 |
| 171 |
KIDNEY INFECTION |
1 |
0.0001 |
| 172 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 173 |
CATARACT |
3 |
0.0001 |
| 174 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 175 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 176 |
SPINAL FRACTURE |
1 |
0.0000 |
| 177 |
TASTE DISORDER |
1 |
0.0000 |
| 178 |
VERTIGO |
3 |
0.0000 |
| 179 |
OSTEOPOROSIS |
2 |
0.0000 |
| 180 |
POLLAKIURIA |
2 |
0.0000 |
| 181 |
ROAD TRAFFIC ACCIDENT |
2 |
0.0000 |
| 182 |
TOXICITY TO VARIOUS AGENTS |
8 |
0.0000 |
| 183 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 184 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 185 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 186 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
0.0000 |
| 187 |
DIABETIC KETOACIDOSIS |
1 |
0.0000 |
| 188 |
LOCALISED INFECTION |
1 |
0.0000 |
| 189 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 190 |
HEART RATE INCREASED |
4 |
0.0000 |
| 191 |
VISUAL IMPAIRMENT |
5 |
0.0000 |
| 192 |
AGEUSIA |
1 |
0.0000 |
| 193 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 194 |
CELLULITIS |
2 |
0.0000 |
| 195 |
HAEMATEMESIS |
1 |
0.0000 |
| 196 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 197 |
HEPATITIS |
1 |
0.0000 |
| 198 |
HAEMOGLOBIN DECREASED |
4 |
0.0000 |
| 199 |
ILLNESS |
4 |
0.0000 |
| 200 |
SKIN ULCER |
1 |
0.0000 |
| 201 |
PANCREATITIS |
2 |
0.0000 |
| 202 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 203 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 204 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 205 |
FEELING COLD |
1 |
0.0000 |
| 206 |
WOUND |
1 |
0.0000 |
| 207 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 208 |
URINARY TRACT INFECTION |
6 |
0.0000 |
| 209 |
ANGINA PECTORIS |
1 |
0.0000 |
| 210 |
HERPES ZOSTER |
2 |
0.0000 |
| 211 |
EYE IRRITATION |
2 |
0.0000 |
| 212 |
BALANCE DISORDER |
3 |
0.0000 |
| 213 |
BONE PAIN |
2 |
0.0000 |
| 214 |
SURGERY |
2 |
0.0000 |
| 215 |
ASCITES |
1 |
0.0000 |
| 216 |
ABDOMINAL PAIN UPPER |
7 |
0.0000 |
| 217 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 218 |
WHEEZING |
2 |
0.0000 |
| 219 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
6 |
0.0000 |
| 220 |
JOINT SWELLING |
4 |
0.0000 |
| 221 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 222 |
OEDEMA PERIPHERAL |
4 |
0.0000 |
| 223 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 224 |
PRODUCT USE ISSUE |
6 |
0.0000 |
| 225 |
HEAD INJURY |
1 |
0.0000 |
| 226 |
NEUROPATHY PERIPHERAL |
3 |
0.0000 |
| 227 |
ANAEMIA |
6 |
0.0000 |
| 228 |
CYSTITIS |
1 |
0.0000 |
| 229 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 230 |
HIP FRACTURE |
1 |
0.0000 |
| 231 |
DEEP VEIN THROMBOSIS |
2 |
0.0000 |
| 232 |
EYE DISORDER |
1 |
0.0000 |
| 233 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
0.0000 |
| 234 |
BLOOD PRESSURE DECREASED |
2 |
0.0000 |
| 235 |
SYNCOPE |
3 |
0.0000 |
| 236 |
URINARY RETENTION |
1 |
0.0000 |
| 237 |
GAIT INABILITY |
1 |
0.0000 |
| 238 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 239 |
FLUSHING |
3 |
0.0000 |
| 240 |
GASTRIC DISORDER |
1 |
0.0000 |
| 241 |
HEART RATE DECREASED |
1 |
0.0000 |
| 242 |
PLATELET COUNT DECREASED |
3 |
0.0000 |
| 243 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 244 |
CONSTIPATION |
6 |
0.0000 |
| 245 |
PANIC ATTACK |
1 |
0.0000 |
| 246 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 247 |
RESTLESSNESS |
1 |
0.0000 |
| 248 |
SEPSIS |
3 |
0.0000 |
| 249 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 250 |
EPISTAXIS |
2 |
0.0000 |
| 251 |
DYSARTHRIA |
1 |
0.0000 |
| 252 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 253 |
INCORRECT DOSE ADMINISTERED |
6 |
0.0000 |
| 254 |
BLOOD PRESSURE INCREASED |
4 |
0.0000 |
| 255 |
ACUTE KIDNEY INJURY |
4 |
0.0000 |
| 256 |
GAIT DISTURBANCE |
5 |
0.0000 |
| 257 |
PERIPHERAL SWELLING |
4 |
0.0000 |
| 258 |
CHILLS |
3 |
0.0000 |
| 259 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 260 |
DYSKINESIA |
1 |
0.0000 |
| 261 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 262 |
INFLUENZA LIKE ILLNESS |
2 |
0.0000 |
| 263 |
LOSS OF CONSCIOUSNESS |
3 |
0.0000 |
| 264 |
HYPOACUSIS |
1 |
0.0000 |
| 265 |
COLITIS ULCERATIVE |
1 |
0.0000 |
| 266 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 267 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 268 |
NEUTROPENIA |
3 |
0.0000 |
| 269 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 270 |
HYPOKALAEMIA |
1 |
0.0000 |
| 271 |
DECREASED APPETITE |
5 |
0.0000 |
| 272 |
RENAL DISORDER |
1 |
0.0000 |
| 273 |
COMA |
1 |
0.0000 |
| 274 |
MIGRAINE |
2 |
0.0000 |
| 275 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 276 |
DRUG INTOLERANCE |
2 |
0.0000 |
| 277 |
INFLAMMATION |
1 |
0.0000 |
| 278 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 279 |
BRADYCARDIA |
1 |
0.0000 |
| 280 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 281 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 282 |
OEDEMA |
1 |
0.0000 |
| 283 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 284 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 285 |
ARTHROPATHY |
1 |
0.0000 |
| 286 |
FATIGUE |
14 |
0.0000 |
| 287 |
HYPONATRAEMIA |
1 |
0.0000 |
| 288 |
CEREBROVASCULAR ACCIDENT |
3 |
0.0000 |
| 289 |
RHEUMATOID ARTHRITIS |
2 |
0.0000 |
| 290 |
CONVULSION |
1 |
0.0000 |
| 291 |
LETHARGY |
1 |
0.0000 |
| 292 |
BACK PAIN |
4 |
0.0000 |
| 293 |
DIARRHOEA |
11 |
0.0000 |
| 294 |
BLADDER CANCER |
1 |
0.0000 |
| 295 |
STOMATITIS |
1 |
0.0000 |
| 296 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 297 |
MUSCLE SPASMS |
3 |
0.0000 |
| 298 |
FEELING HOT |
1 |
0.0000 |
| 299 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 300 |
PAIN |
10 |
0.0000 |
| 301 |
CHEST PAIN |
3 |
0.0000 |
| 302 |
HYPERSENSITIVITY |
3 |
0.0000 |
| 303 |
RASH |
7 |
0.0000 |
| 304 |
DIZZINESS |
8 |
0.0000 |
| 305 |
ASTHENIA |
6 |
0.0000 |
| 306 |
HYPERHIDROSIS |
2 |
0.0000 |
| 307 |
AMNESIA |
1 |
0.0000 |
| 308 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 309 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 310 |
INSOMNIA |
4 |
0.0000 |
| 311 |
DEHYDRATION |
2 |
0.0000 |
| 312 |
HYPOTENSION |
3 |
0.0000 |
| 313 |
SOMNOLENCE |
3 |
0.0000 |
| 314 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
3 |
0.0000 |
| 315 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 316 |
PYREXIA |
5 |
0.0000 |
| 317 |
SLEEP DISORDER |
1 |
0.0000 |
| 318 |
HYPERTENSION |
3 |
0.0000 |
| 319 |
INFECTION |
2 |
0.0000 |
| 320 |
OFF LABEL USE |
12 |
0.0000 |
| 321 |
MALAISE |
6 |
0.0000 |
| 322 |
PAIN IN EXTREMITY |
4 |
0.0000 |
| 323 |
BRONCHITIS |
1 |
0.0000 |
| 324 |
DYSGEUSIA |
1 |
0.0000 |
| 325 |
HYPOAESTHESIA |
2 |
0.0000 |
| 326 |
ACNE |
1 |
0.0000 |
| 327 |
DEPRESSION |
3 |
0.0000 |
| 328 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 329 |
CONDITION AGGRAVATED |
4 |
0.0000 |
| 330 |
CARDIAC FAILURE |
1 |
0.0000 |
| 331 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 332 |
DRY MOUTH |
1 |
0.0000 |
| 333 |
CARDIAC ARREST |
1 |
0.0000 |
| 334 |
TREATMENT FAILURE |
1 |
0.0000 |
| 335 |
FALL |
4 |
0.0000 |
| 336 |
COMPLETED SUICIDE |
1 |
0.0000 |
| 337 |
MYALGIA |
2 |
0.0000 |
| 338 |
NAUSEA |
9 |
0.0000 |
| 339 |
TACHYCARDIA |
1 |
0.0000 |
| 340 |
HEADACHE |
7 |
0.0000 |
| 341 |
NO ADVERSE EVENT |
2 |
0.0000 |
| 342 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 343 |
ADVERSE EVENT |
1 |
0.0000 |
| 344 |
COUGH |
3 |
0.0000 |
| 345 |
CARDIAC DISORDER |
1 |
0.0000 |
| 346 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 347 |
DYSPHAGIA |
1 |
0.0000 |
| 348 |
PRURITUS |
4 |
0.0000 |
| 349 |
CONTUSION |
1 |
0.0000 |
| 350 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 351 |
DYSPEPSIA |
1 |
0.0000 |
| 352 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 353 |
SINUSITIS |
1 |
0.0000 |
| 354 |
HAEMORRHAGE |
1 |
0.0000 |
| 355 |
OVERDOSE |
2 |
0.0000 |
| 356 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 357 |
WEIGHT INCREASED |
2 |
0.0000 |
| 358 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 359 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 360 |
VOMITING |
4 |
0.0000 |
| 361 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 362 |
RENAL FAILURE |
1 |
0.0000 |
| 363 |
DRY SKIN |
1 |
0.0000 |
| 364 |
VISION BLURRED |
1 |
0.0000 |
| 365 |
ARTHRALGIA |
3 |
0.0000 |
| 366 |
WEIGHT DECREASED |
2 |
0.0000 |
| 367 |
ANXIETY |
2 |
0.0000 |
| 368 |
DEATH |
6 |
0.0000 |
| 369 |
PRODUCT DOSE OMISSION ISSUE |
2 |
0.0000 |
| 370 |
PARAESTHESIA |
1 |
0.0000 |
| 371 |
DRUG INTERACTION |
1 |
0.0000 |
| 372 |
PNEUMONIA |
2 |
0.0000 |
| 373 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 374 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 375 |
DYSPNOEA |
3 |
0.0000 |
| 376 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 377 |
FEELING ABNORMAL |
1 |
0.0000 |